NCT04481230View on ClinicalTrials.gov

Assessment of 99mTc-NTP 15-5 Uptake on Cartilage, a New Proteoglycan Tracer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 12, 2020

Primary Completion Date

July 28, 2022

Study Completion Date

September 19, 2022

Conditions
Osteoarthritis, KneeBreast Cancer
Interventions
DRUG

99mTc-NTP 15-5 at a diagnostic activity of 5 MBq/kg

1 intravenous injection of 99mTc-NTP 15-5 at a diagnostic activity of 5 MBq/kg (D0)

DRUG

99mTc-NTP 15-5 at a diagnostic activity of 10 MBq/kg

1 intravenous injection of 99mTc-NTP 15-5 at a diagnostic activity of 10 MBq/kg (D0)

DRUG

99mTc-NTP 15-5 at a diagnostic activity of 15 MBq/kg

1 intravenous injection of 99mTc-NTP 15-5 at a diagnostic activity of 15 MBq/kg (D0)

Trial Locations (2)

63011

Centre Jean Perrin, Clermont-Ferrand

Unknown

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

Centre Jean Perrin

OTHER

NCT04481230 - Assessment of 99mTc-NTP 15-5 Uptake on Cartilage, a New Proteoglycan Tracer | Biotech Hunter | Biotech Hunter